MOL CANCER 潤色咨詢

Molecular Cancer

出版年份:2002 年文章數(shù):971 投稿命中率: 開通期刊會員,數(shù)據(jù)隨心看

出版周期:Irregular 自引率:2.0% 審稿周期: 開通期刊會員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費用
暫無數(shù)據(jù)
版面費用
4290.0元/篇 (網(wǎng)友貢獻(xiàn),非官方數(shù)據(jù))
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量暫無數(shù)據(jù) (2022年為69.43%)
自引率
2.0 %
年文章數(shù)
971
期刊官網(wǎng)
點擊查看 (點擊次數(shù):26384)
投稿鏈接
點擊查看 (點擊次數(shù):10544次)
作者需知
點擊查看 (點擊次數(shù):3580次)
期刊簡介
稿件收錄要求

Published by BioMed Central. ISSN: 1476-4598.

Molecular Cancer is an Open Access, peer-reviewed online journal interested in original research and commentary in all areas of cancer and related biomedical science. Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Molecular Cancer will consider articles from any area of cancer-related biomedical research, including, but not limited to: angiogenesis; animal models; metastasis; cancer antigens and the immune response to them; cellular signalling and molecular biology; epidemiology; genetic and molecular profiling of cancer; prevention, diagnosis and therapy of cancer; and vaccine- and antibody-based cancer therapies. Molecular Cancer, a forum for exciting findings in the field of cancer-related research, is an Open Access journal, providing an unparalleled opportunity to present information to specialists and the public. The online appearance of Molecular Cancer allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information.